BeStock  
Stocks › Biotechnology › ZVRA

Zevra Therapeutics ZVRA

US equityMarket cap rank #3557Biotechnology
$11.08 +$0.35 (+3.26%)
Pre-market · Oct 8, 7:00 am ET · After hours $11.19 +0.99%
Open$10.68
Prev close$10.73
Day range$10.57 – $11.38
Volume936.5K
Market cap$657.97M
P/E (TTM)11.9
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$25.25+127.9% vs. price
  • Buy 100%
Low $20.00Now $11.08Avg $25.25High $35.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $35.00, averaging $24.56.

DateFirmRatingTarget
30 Sep 2026 William Blair BUY –
21 Sep 2026 H.C. Wainwright BUY $26.00
21 Aug 2026 H.C. Wainwright BUY $26.00
20 Aug 2026 H.C. Wainwright BUY $26.00
11 Aug 2026 CCORF BUY $20.00
6 Aug 2026 Maxim Group BUY $35.00
6 Aug 2026 Citizens JMP BUY $28.00
6 Aug 2026 Guggenheim BUY $23.00
6 Aug 2026 Roth MKM BUY $21.00
6 Aug 2026 H.C. Wainwright BUY $26.00
5 Aug 2026 Cantor Fitzgerald BUY $25.00
5 Aug 2026 CCORF BUY $20.00
5 Aug 2026 BTIG BUY $24.00
27 Jul 2026 CCORF BUY $20.00
27 Jul 2026 BTIG BUY $24.00
24 Jul 2026 Guggenheim BUY $24.00
24 Jul 2026 Roth MKM BUY $21.00
24 Jul 2026 H.C. Wainwright BUY $26.00
1 Jul 2026 BTIG BUY $27.00
24 Jun 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on ZVRA.

Leave a comment

Scroll to Top